Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > NM Providers

Dr. Robert Amjad Ali, MD

(No ratings)

Specializes in: Adult Oncology and Adult Hematology

University of the West Indies Faculty of Medical Sciences

101 S Canal Street
Carlsbad, NM 88220

(575) 234-1466

Dr. Robert Amjad Ali, MD is an oncologist in Carlsbad, NM specializing in adult oncology and adult hematology. He graduated from University of the West Indies Faculty of Medical Sciences. Dr. Robert Amjad Ali, MD is affiliated with CHRISTUS Health and ST VINCENT HOSPITAL.

Office Locations

101 S Canal Street
Carlsbad, NM 88220

(575) 234-1466

(575) 628-1099

open_in_new

445 St Michaels Drive
Santa Fe, NM 87505

open_in_new

655 W 8th Street
Jacksonville, FL 32209

(904) 383-1003

(904) 244-7388

open_in_new

Noteworthy Medicare Patient Procedures Performed by Dr. Robert Amjad Ali, MD in 2023

Click on any procedure below to see further details on volume and pricing among Medicare patients.

Top 5%

By Volume:

abdominal CT scan

pelvic CT scan

serum folate test

By Affordability:

A1C test

albumin test

antigen tests

antineoplastic hormone therapy

blood differential tests

blood draw

blood draw for lab tests

blood smear

blood tests

cancer antigen tests

carcinoembryonic antigen test

chest CT scan

cholesterol screening

coagulation tests

complete blood count

C-reactive protein testing

creatinine test

creatinine urine test

CT scan

diabetes management

diabetes screening

glycated protein test

intravenous infusion therapy

intravenous infusion

kidney function tests

lactate dehydrogenase test

microalbumin urine test

phlebotomy for lab tests

prostate-specific antigen test

prothrombin time test

quantitative Ig tests

white blood cell differential

In 2023, among providers in related specialties within New Mexico, Dr. Robert Amjad Ali, MD performed more abdominal CT scan, pelvic CT scan, and serum folate test procedures for Medicare patients than 95% of them and he also had a list price for A1C test, albumin test, antigen tests, antineoplastic hormone therapy, blood differential tests, blood draw, blood draw for lab tests, blood smear, blood tests, cancer antigen tests, carcinoembryonic antigen (CEA) test, chest CT scan, cholesterol screening, coagulation (blood clotting) tests, complete blood count (CBC), C-reactive protein testing, creatinine test, creatinine urine test, CT scan, diabetes management, diabetes screening, glycated protein test, hormone therapy, IgA test, IgD test, IgG test, IgM test, immunoglobulin tests, intravenous infusion therapy, intravenous (IV) infusion, kidney function tests, lactate dehydrogenase (LDH) test, lipid profile, liver function tests (LFTs), magnesium test, microalbumin test, microalbumin urine test, phlebotomy for lab tests, prostate-specific antigen (PSA) test, prothrombin time (PT) test, quantitative Ig tests, reticulocyte count (immature red blood cell count), sed rate (ESR), testosterone test, thoracic (chest) imaging, total IgA test, total IgG test, total PSA test, uric acid blood test, uric acid test, urinalysis, venipuncture (phlebotomy), vitamin D test, and white blood cell (WBC) differential that was lower than the list prices billed to Medicare by 95% of them. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.

Top 10%

By Volume:

lab tests

screening test

By Affordability:

port flush

In 2023, among providers in related specialties within New Mexico, Dr. Robert Amjad Ali, MD performed more lab tests, and screening test procedures for Medicare patients than 90% of them and he also had a list price for port flush that was lower than the list prices billed to Medicare by 90% of them. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.

Top 25%

By Volume:

antineoplastic hormone therapy

biological response modifier therapy

blood draw

intravenous chemotherapy

intravenous infusion

lipid profile

phlebotomy for lab tests

total PSA test

By Affordability:

iron tests

In 2013, among providers in related specialties within New Mexico, Dr. Robert Amjad Ali, MD performed more antineoplastic hormone therapy, biological response modifier (BRM) therapy, blood draw, intravenous (IV) chemotherapy, intravenous (IV) infusion, lipid profile, phlebotomy for lab tests, and total PSA test procedures for Medicare patients than 75% of them and he also had a list price for iron tests that was lower than the list prices billed to Medicare by 75% of them. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.

Medicare Procedure and Patient Information

2019 Medicare Procedure Volume

The top procedures that Dr. Robert Amjad Ali, MD treated as an oncologist in Carlsbad, NM during 2019 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Robert Amjad Ali, MD for Medicare patients.

biological response modifier (BRM) therapy	225
blood draw	587
chemotherapy	225
doctor visit	697
lab tests	1734
minimally invasive procedures	250
port flush	27
thyroid function tests	42

2019 Medicare Patient Data

Information about Medicare patients treated by Dr. Robert Amjad Ali, MD.

**Gender**
Male	114
Female	214

**Ethnicity**
Non-Hispanic White	188
Black	0
Hispanic	124
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	131
From 75 to 84	93
85 and over	39
Less than 65	65

Conditions of Medicare patients treated by Dr. Robert Amjad Ali, MD in 2019

The most common conditions of Medicare patients that Dr. Robert Amjad Ali, MD treated during 2019 were hypertension, high cholesterol, diabetes and ischemic heart disease.

Hypertension	75
High Cholesterol	65
Stroke	5
Ischemic Heart Disease	40
Depression	26
Chronic Kidney Disease	39
Asthma	7
Osteoperosis	10
Atrial Fibrilation	11
Heart Failure	19
Chronic Obstructive Pulmonary Disease	25
Diabetes	40
Dementia	9
Cancer	37

Medicare Procedure and Patient Information

2020 Medicare Procedure Volume

The top procedures that Dr. Robert Amjad Ali, MD treated as an oncologist in Carlsbad, NM during 2020 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Robert Amjad Ali, MD for Medicare patients.

biological response modifier (BRM) therapy	458
blood draw	1189
chemotherapy	458
doctor visit	1445
hormone therapy	52
lab tests	3585
minimally invasive procedures	486
port flush	44
preventive care	32
thyroid function tests	61
vaccines	14

2020 Medicare Patient Data

Information about Medicare patients treated by Dr. Robert Amjad Ali, MD.

**Gender**
Male	189
Female	317

**Ethnicity**
Non-Hispanic White	311
Black	17
Hispanic	167
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	203
From 75 to 84	163
85 and over	61
Less than 65	79

Conditions of Medicare patients treated by Dr. Robert Amjad Ali, MD in 2020

The most common conditions of Medicare patients that Dr. Robert Amjad Ali, MD treated during 2020 were hypertension, high cholesterol, chronic kidney disease and diabetes.

Hypertension	75
High Cholesterol	59
Stroke	4
Ischemic Heart Disease	37
Depression	23
Chronic Kidney Disease	41
Asthma	8
Osteoperosis	11
Atrial Fibrilation	10
Heart Failure	19
Chronic Obstructive Pulmonary Disease	24
Diabetes	41
Dementia	11
Cancer	32

Medicare Procedure and Patient Information

2021 Medicare Procedure Volume

The top procedures that Dr. Robert Amjad Ali, MD treated as an oncologist in Carlsbad, NM during 2021 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Robert Amjad Ali, MD for Medicare patients.

biological response modifier (BRM) therapy	517
blood draw	1537
chemotherapy	517
diabetes management	21
doctor visit	1671
hormone therapy	100
lab tests	4669
minimally invasive procedures	537
port flush	55
preventive care	83
thyroid function tests	120
vaccines	14

2021 Medicare Patient Data

Information about Medicare patients treated by Dr. Robert Amjad Ali, MD.

**Gender**
Male	238
Female	384

**Ethnicity**
Non-Hispanic White	406
Black	13
Hispanic	190
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	271
From 75 to 84	197
85 and over	81
Less than 65	73

Conditions of Medicare patients treated by Dr. Robert Amjad Ali, MD in 2021

The most common conditions of Medicare patients that Dr. Robert Amjad Ali, MD treated during 2021 were hypertension, high cholesterol, chronic kidney disease and diabetes.

Hypertension	75
High Cholesterol	67
Stroke	4
Ischemic Heart Disease	37
Depression	20
Chronic Kidney Disease	44
Asthma	6
Osteoperosis	12
Atrial Fibrilation	10
Heart Failure	21
Chronic Obstructive Pulmonary Disease	18
Diabetes	41
Dementia	13
Cancer	37

Medicare Procedure and Patient Information

2022 Medicare Procedure Volume

The top procedures that Dr. Robert Amjad Ali, MD treated as an oncologist in Carlsbad, NM during 2022 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Robert Amjad Ali, MD for Medicare patients.

abdominal imaging	19
biological response modifier (BRM) therapy	442
blood draw	1541
cardiac procedures	17
chemotherapy	442
CT scan	43
diabetes management	29
doctor visit	1708
hormone therapy	146
lab tests	4996
minimally invasive procedures	493
pelvic imaging	19
port flush	66
preventive care	70
thoracic (chest) imaging	24
thyroid function tests	111
ultrasound (sonogram)	17

2022 Medicare Patient Data

Information about Medicare patients treated by Dr. Robert Amjad Ali, MD.

**Gender**
Male	221
Female	382

**Ethnicity**
Non-Hispanic White	391
Black	13
Hispanic	186
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	252
From 75 to 84	201
85 and over	80
Less than 65	70

Conditions of Medicare patients treated by Dr. Robert Amjad Ali, MD in 2022

The most common conditions of Medicare patients that Dr. Robert Amjad Ali, MD treated during 2022 were high cholesterol, hypertension, cancer and diabetes.

Hypertension	75
High Cholesterol	75
Stroke	8
Ischemic Heart Disease	26
Depression	17
Chronic Kidney Disease	26
Asthma	11
Osteoperosis	21
Atrial Fibrilation	17
Heart Failure	15
Chronic Obstructive Pulmonary Disease	21
Diabetes	40
Dementia	7
Cancer	43

Medicare Procedure and Patient Information

2023 Medicare Procedure Volume

The top procedures that Dr. Robert Amjad Ali, MD treated as an oncologist in Carlsbad, NM during 2023 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Robert Amjad Ali, MD for Medicare patients.

abdominal imaging	52
biological response modifier (BRM) therapy	347
blood draw	1221
chemotherapy	347
CT scan	107
diabetes management	26
doctor visit	1468
hormone therapy	102
lab tests	4648
minimally invasive procedures	391
pelvic imaging	52
port flush	60
preventive care	54
thoracic (chest) imaging	55
thyroid function tests	99

2023 Medicare Patient Data

Information about Medicare patients treated by Dr. Robert Amjad Ali, MD.

**Gender**
Male	195
Female	312

**Ethnicity**
Non-Hispanic White	327
Black	13
Hispanic	156
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	213
From 75 to 84	179
85 and over	65
Less than 65	50

Conditions of Medicare patients treated by Dr. Robert Amjad Ali, MD in 2023

The most common conditions of Medicare patients that Dr. Robert Amjad Ali, MD treated during 2023 were high cholesterol, hypertension, diabetes and cancer.

Hypertension	75
High Cholesterol	75
Stroke	10
Ischemic Heart Disease	27
Depression	19
Chronic Kidney Disease	28
Asthma	9
Osteoperosis	21
Atrial Fibrilation	16
Heart Failure	15
Chronic Obstructive Pulmonary Disease	21
Diabetes	44
Dementia	5
Cancer	43

Medicare Procedure and Patient Information

Average Medicare Procedure Volume From 2019 - 2023

Volume of procedures performed by Dr. Robert Amjad Ali, MD for Medicare patients.

The highest averages for the top procedures that Dr. Robert Amjad Ali, MD treated as an oncologist in Carlsbad, NM were lab tests, blood draw, minimally invasive procedures and chemotherapy.

abdominal imaging	35
biological response modifier (BRM) therapy	397
blood draw	1215
cardiac procedures	17
chemotherapy	397
CT scan	75
diabetes management	25
doctor visit	1397
hormone therapy	100
lab tests	3926
minimally invasive procedures	431
pelvic imaging	35
preventive care	59
thoracic (chest) imaging	39
thyroid function tests	86
ultrasound (sonogram)	17
vaccines	14

Average Medicare Patient Data From 2019 - 2023

Information about Medicare patients treated by Dr. Robert Amjad Ali, MD.

**Gender**
Male	191
Female	321

**Ethnicity**
Black / African American	11
Asian / Pacific Islander	0
Non-Hispanic White	324
Native American / Alaskan Native	0
Hispanic	164
Other	0

**Age**
75 to 84	166
85 and over	65
Less than 65	67
65 to 74	214

Average of Total of Conditions of Medicare patients treated by Dr. Robert Amjad Ali, MD From 2019 - 2023

The highest averages of the most common conditions of Medicare patients that Dr. Robert Amjad Ali, MD treated were hypertension, high cholesterol, diabetes and cancer.

Hypertension	75
High Cholesterol	68
Stroke	6
Ischemic Heart Disease	33
Depression	21
Chronic Kidney Disease	35
Asthma	8
Osteoporosis	15
Heart Failure	17
Chronic Obstructive Pulmonary Disease	21
Diabetes	41
Atrial Fibrillation	12
Cancer	38
Dementia	9

Education & Training

Dr. Robert Amjad Ali, MD graduated from University of the West Indies Faculty of Medical Sciences. He completed residency at University of Florida Health Science Center and Affiliated Hospitals. He is certified by the Certification: American Board of Internal Medicine and has a state license in New Mexico.

Medical School: University of the West Indies Faculty of Medical Sciences

Residency: University of Florida Health Science Center and Affiliated Hospitals

Board Certification: Certification: American Board of Internal Medicine

Licensed In: New Mexico

Affiliations & Hospitals

Dr. Robert Amjad Ali, MD is associated with these hospitals and organizations:

CHRISTUS Health

ST VINCENT HOSPITAL

Insurance Information

Please note: Insurance information may change at any time, and the provider may accept your insurance plan even if it is not listed below. Please contact the provider's office to confirm that your insurance is accepted.

Dr. Robert Amjad Ali, MD appears to accept the following insurance providers: Blue California.

Insurance Accepted by Provider includes:

According to our sources, Dr. Robert Amjad Ali, MD accepts the following insurance providers:

Blue California

Ratings & Reviews

Dr. Robert Amjad Ali, MD does not have any reviews yet, be the first to leave a review of Dr. Robert Amjad Ali, MD here: Leave a Review

(No ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Robert Amjad Ali, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
Novartis Pharmaceuticals Corporation	$1,366 KISQALI $329	TASIGNA $266	AFINITOR $146	SCEMBLIX $103	PROMACTA $98	Other $424
E.R. Squibb & Sons, L.L.C.	$936 EMPLICITI $407	OPDIVO $366	OPDUALAG $61	Reblozyl $27	KRAZATI $17	Other $58
AstraZeneca Pharmaceuticals LP	$716 LYNPARZA $146	IMFINZI $96	TAGRISSO $95	FASLODEX $40	Enhertu $36	Other $303
Janssen Biotech, Inc.	$663 IMBRUVICA $163	TECVAYLI $140	Erleada $127	DARZALEX $125	Balversa $56	Other $52
Celgene Corporation	$499 Revlimid $359	Reblozyl $88	Abraxane $52
Other	$5,737 KEYTRUDA $377	ADCETRIS $315	JAKAFI $240	Injectafer $219	Cabometyx $189	Other $4,397

**Types of Payments**
Food and Beverage	$9,114
Education	$804

Biography

Dr. Robert Ali practices adult hematology and adult oncology. Dr. Ali can take Blue California insurance. He attended the University of the West Indies Faculty of Medical Sciences and then went on to complete his residency at a hospital affiliated with the University of Florida Health Science Center. He is affiliated with CHRISTUS St. Vincent Regional Medical Center.